Aminoglycoside (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aminoglycoside" in English language version.

refsWebsite

Global rank English rank

20nih.gov

4^th place

17doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

3web.archive.org

1^st place

2merckmanuals.com

3,097^th place

2,317^th place

2merckvetmanual.com

9,011^th place

6,167^th place

2harvard.edu

18^th place

17^th place

1msdmanuals.com

4,047^th place

8,904^th place

doi.org

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). "Aminoglycosides: activity and resistance". Antimicrob. Agents Chemother. 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Kroppenstedt RM, Mayilraj S, Wink JM (June 2005). "Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov". Syst Appl Microbiol. 28 (4): 328–39. doi:10.1016/j.syapm.2004.12.011. PMID 15997706.
Walter P. Hammes1 and Francis C. Neuhaus (1974). "On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari". Antimicrobial Agents and Chemotherapy. 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Aguirre Rivera, Javier (2021). "Real-time measurements of aminoglycoside effects on protein synthesis in live cells". Proceedings of the National Academy of Sciences. 118 (9): e2013315118. Bibcode:2021PNAS..11813315A. doi:10.1073/pnas.2013315118. PMC 7936356. PMID 33619089.
Feero, W. Gregory; Guttmacher, Alan E.; Dietz, Harry C. (2010). "New Therapeutic Approaches to Mendelian Disorders". New England Journal of Medicine. 363 (9): 852–63. doi:10.1056/NEJMra0907180. PMID 20818846. S2CID 5809127.
Wilschanski, Michael; Yahav, Yaacov; Yaacov, Yasmin; Blau, Hannah; Bentur, Lea; Rivlin, Joseph; Aviram, Micha; Bdolah-Abram, Tali; et al. (2003). "Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations". New England Journal of Medicine. 349 (15): 1433–41. doi:10.1056/NEJMoa022170. PMID 14534336.
Pai VB, Nahata MC (October 2001). "Efficacy and safety of aerosolized tobramycin in cystic fibrosis". Pediatr. Pulmonol. 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Falagas, Matthew E; Grammatikos, Alexandros P; Michalopoulos, Argyris (2008). "Potential of old-generation antibiotics to address current need for new antibiotics". Expert Review of Anti-infective Therapy. 6 (5): 593–600. doi:10.1586/14787210.6.5.593. PMID 18847400. S2CID 13158593.
Durante-Mangoni, Emanuele; Grammatikos, Alexandros; Utili, Riccardo; Falagas, Matthew E. (2009). "Do we still need the aminoglycosides?". International Journal of Antimicrobial Agents. 33 (3): 201–5. doi:10.1016/j.ijantimicag.2008.09.001. PMID 18976888.
Selimoglu, Erol (2007). "Aminoglycoside-induced ototoxicity". Current Pharmaceutical Design. 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591.
L, Peterson; C, Rogers (18 February 2015). "Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity". South African Family Practice. 57 (2): 77–82. doi:10.1080/20786190.2014.1002220.
Black, FO; Pesznecker, S; Stallings, V (July 2004). "Permanent gentamicin vestibuloxicity". Otology and Neurotology. 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; Hannigan, IP; MacDougall, HG; Chan, RC; Halmagyi, GM (18 June 2012). "Gentamicin ototoxicity: a 23-year selected case series of 103 patients". Medical Journal of Australia. 196 (11): 701–4. doi:10.5694/mja11.10850. PMID 22554194.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). "Unilateral vestibular loss due to systemically administered gentamicin". Otology and Neurotology. 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). "Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex". Acta Otolaryngologica. 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). "Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis". Thorax. 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.
referenced in Bindu, LH; Reddy, PP (2008). "Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review". Int J Audiol. 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). "Genetic factors in aminoglycoside toxicity". Ann N Y Acad Sci. 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

harvard.edu

ui.adsabs.harvard.edu

Aguirre Rivera, Javier (2021). "Real-time measurements of aminoglycoside effects on protein synthesis in live cells". Proceedings of the National Academy of Sciences. 118 (9): e2013315118. Bibcode:2021PNAS..11813315A. doi:10.1073/pnas.2013315118. PMC 7936356. PMID 33619089.
referenced in Bindu, LH; Reddy, PP (2008). "Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review". Int J Audiol. 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). "Genetic factors in aminoglycoside toxicity". Ann N Y Acad Sci. 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

merckmanuals.com

ME Levison, MD, 2012, Aminoglycosides, The Merck Manual [1], accessed 22 February 2014.
Merck Manual: Bacteria and Antibacterial Drugs: Aminoglycosides Last full review/revision July 2009 by Matthew E. Levison, MD

merckvetmanual.com

DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual "Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual". Archived from the original on 2014-03-01. Retrieved 2014-02-22., accessed 22 February 2014.
As Boothe notes, "high concentrations of aminoglycosides may cause nonspecific membrane toxicity, even to the point of bacterial cell lysis", though the physiologic relevance of these concentrations to specific clinical situations is unclear. DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual "Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual". Archived from the original on 2014-03-01. Retrieved 2014-02-22., accessed 22 February 2014.

msdmanuals.com

"Aminoglycosides - Infectious Diseases". MSD Manual Professional Edition. Retrieved 2021-12-14.

nih.gov

pubmed.ncbi.nlm.nih.gov

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). "Aminoglycosides: activity and resistance". Antimicrob. Agents Chemother. 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Kroppenstedt RM, Mayilraj S, Wink JM (June 2005). "Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov". Syst Appl Microbiol. 28 (4): 328–39. doi:10.1016/j.syapm.2004.12.011. PMID 15997706.
Walter P. Hammes1 and Francis C. Neuhaus (1974). "On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari". Antimicrobial Agents and Chemotherapy. 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Aguirre Rivera, Javier (2021). "Real-time measurements of aminoglycoside effects on protein synthesis in live cells". Proceedings of the National Academy of Sciences. 118 (9): e2013315118. Bibcode:2021PNAS..11813315A. doi:10.1073/pnas.2013315118. PMC 7936356. PMID 33619089.
Feero, W. Gregory; Guttmacher, Alan E.; Dietz, Harry C. (2010). "New Therapeutic Approaches to Mendelian Disorders". New England Journal of Medicine. 363 (9): 852–63. doi:10.1056/NEJMra0907180. PMID 20818846. S2CID 5809127.
Wilschanski, Michael; Yahav, Yaacov; Yaacov, Yasmin; Blau, Hannah; Bentur, Lea; Rivlin, Joseph; Aviram, Micha; Bdolah-Abram, Tali; et al. (2003). "Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations". New England Journal of Medicine. 349 (15): 1433–41. doi:10.1056/NEJMoa022170. PMID 14534336.
Pai VB, Nahata MC (October 2001). "Efficacy and safety of aerosolized tobramycin in cystic fibrosis". Pediatr. Pulmonol. 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Falagas, Matthew E; Grammatikos, Alexandros P; Michalopoulos, Argyris (2008). "Potential of old-generation antibiotics to address current need for new antibiotics". Expert Review of Anti-infective Therapy. 6 (5): 593–600. doi:10.1586/14787210.6.5.593. PMID 18847400. S2CID 13158593.
Durante-Mangoni, Emanuele; Grammatikos, Alexandros; Utili, Riccardo; Falagas, Matthew E. (2009). "Do we still need the aminoglycosides?". International Journal of Antimicrobial Agents. 33 (3): 201–5. doi:10.1016/j.ijantimicag.2008.09.001. PMID 18976888.
Selimoglu, Erol (2007). "Aminoglycoside-induced ototoxicity". Current Pharmaceutical Design. 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591.
Black, FO; Pesznecker, S; Stallings, V (July 2004). "Permanent gentamicin vestibuloxicity". Otology and Neurotology. 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; Hannigan, IP; MacDougall, HG; Chan, RC; Halmagyi, GM (18 June 2012). "Gentamicin ototoxicity: a 23-year selected case series of 103 patients". Medical Journal of Australia. 196 (11): 701–4. doi:10.5694/mja11.10850. PMID 22554194.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). "Unilateral vestibular loss due to systemically administered gentamicin". Otology and Neurotology. 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). "Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex". Acta Otolaryngologica. 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). "Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis". Thorax. 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.
referenced in Bindu, LH; Reddy, PP (2008). "Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review". Int J Audiol. 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). "Genetic factors in aminoglycoside toxicity". Ann N Y Acad Sci. 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

ncbi.nlm.nih.gov

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). "Aminoglycosides: activity and resistance". Antimicrob. Agents Chemother. 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Walter P. Hammes1 and Francis C. Neuhaus (1974). "On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari". Antimicrobial Agents and Chemotherapy. 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Aguirre Rivera, Javier (2021). "Real-time measurements of aminoglycoside effects on protein synthesis in live cells". Proceedings of the National Academy of Sciences. 118 (9): e2013315118. Bibcode:2021PNAS..11813315A. doi:10.1073/pnas.2013315118. PMC 7936356. PMID 33619089.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). "Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis". Thorax. 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.

semanticscholar.org

api.semanticscholar.org

Feero, W. Gregory; Guttmacher, Alan E.; Dietz, Harry C. (2010). "New Therapeutic Approaches to Mendelian Disorders". New England Journal of Medicine. 363 (9): 852–63. doi:10.1056/NEJMra0907180. PMID 20818846. S2CID 5809127.
Pai VB, Nahata MC (October 2001). "Efficacy and safety of aerosolized tobramycin in cystic fibrosis". Pediatr. Pulmonol. 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Falagas, Matthew E; Grammatikos, Alexandros P; Michalopoulos, Argyris (2008). "Potential of old-generation antibiotics to address current need for new antibiotics". Expert Review of Anti-infective Therapy. 6 (5): 593–600. doi:10.1586/14787210.6.5.593. PMID 18847400. S2CID 13158593.
Black, FO; Pesznecker, S; Stallings, V (July 2004). "Permanent gentamicin vestibuloxicity". Otology and Neurotology. 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). "Unilateral vestibular loss due to systemically administered gentamicin". Otology and Neurotology. 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). "Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex". Acta Otolaryngologica. 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
referenced in Bindu, LH; Reddy, PP (2008). "Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review". Int J Audiol. 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). "Genetic factors in aminoglycoside toxicity". Ann N Y Acad Sci. 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

web.archive.org

The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome Martin Lovmar and Måns Ehrenberg
DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual "Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual". Archived from the original on 2014-03-01. Retrieved 2014-02-22., accessed 22 February 2014.
As Boothe notes, "high concentrations of aminoglycosides may cause nonspecific membrane toxicity, even to the point of bacterial cell lysis", though the physiologic relevance of these concentrations to specific clinical situations is unclear. DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual "Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual". Archived from the original on 2014-03-01. Retrieved 2014-02-22., accessed 22 February 2014.